Brief: AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
29/02/2024 22:41
Feb 29 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL SUBMITS RESPONSE TO FDA, RESUMING REVIEW
CLOCK FOR
RECELL GO PMA SUPPLEMENT
* AVITA MEDICAL INC - EXPECT FDA APPROVAL ON MAY 30, 2024,
POSITIONING US FOR A PRODUCT LAUNCH ON MAY 31, 2024
Source text for Eikon: ID:nGNXbrh0pr
Further company coverage: RCEL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing